U.S. Dentists still prescribe opioids at higher rates globally Recent data shows that despite national efforts to reduce opioid prescribing, U.S. Dentists continue to prescribe opioid pain medications at significantly higher rates compared to dentists in other developed countries. This persistent disparity raises concerns about patient safety and the long-term risks of opioid exposure following routine dental procedures. Studies indicate that while overall opioid prescribing in dentistry has declined in recent years due to updated guidelines and increased awareness of addiction risks, the United States still exceeds international benchmarks. For example, research published in JAMA Network Open found that the U.S. Dental opioid dispensing rate—measured as the number of opioid prescriptions per 100,000 people—remains substantially higher than in countries like the United Kingdom and Australia, even after adjusting for population and procedure volume. One contributing factor is the continued leverage of opioids for managing acute pain after common dental treatments such as tooth extractions, particularly in young adults. Although non-opioid alternatives like ibuprofen and acetaminophen are effective for most dental pain and carry fewer risks, opioids are still frequently prescribed in certain clinical settings. Public health experts emphasize that minimizing opioid exposure, especially among adolescents and young adults, is critical to preventing long-term use and dependence. Updated clinical guidelines from dental associations now recommend nonsteroidal anti-inflammatory drugs (NSAIDs) as first-line therapy for acute dental pain, reserving opioids only for cases where they are truly necessary and under close supervision. Ongoing surveillance and education efforts aim to further align U.S. Prescribing practices with global standards. However, closing the gap will require sustained commitment from dental providers, healthcare systems and policymakers to prioritize patient safety and evidence-based pain management.
51